Glenn Paradis, BA, CFAGemini Gemonics PLCGMNIDON'T BUYOct 13, 2000

Still have to have their technology valuated

Glenn Paradis, BA, CFA

Unknown

Unlock Rating

$10.00

Stock price when the opinion was issued

biotechnologypharmaceutical

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

Most Recent Experts

Jim Cramer - Mad Money

CNBC

Kim Bolton

Black Swan Dexteritas

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Barry Schwartz

Baskin Wealth Management

Larry Berman CFA, CMT, CTA

ETF Capital Management Inc.

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Glenn Paradis, BA, CFAGemini Gemonics PLCGMNIDON'T BUYOct 13, 2000

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals